Prevalence and Associated Factors of Viral Hepatitis B in a High-Security-Risk Environment, Ouargaye, 2025
DOI:
https://doi.org/10.64707/revstss.v49i1.2206Keywords:
hepatitis B, prevalence, risk factorAbstract
Introduction
Despite efforts to strengthen the fight against this disease, viral hepatitis B remains a public health problem in Burkina Faso.
The objective of our study is to describe the prevalence and associated factors of viral hepatitis B in a context of significant security challenges.
Method
This was a cross-sectional study covering the period from December 2025 to February 2026 and including individuals aged 15 years and older. Sampling was exhaustive and included participants in the hepatitis B screening campaign. Socio-demographic, behavioral, and clinical data were collected using a data collection form and subsequently entered into an ODK electronic form. Data analysis was performed using Stata software, and we calculated proportions.
Results
The mean age of participants was 41.72, with women constituting the majority (67.19%). Internally displaced persons accounted for 46.63%. As for the reason for participation, nearly all participants wanted to know their serological status (99.24%), and 94.57% reported no history of hepatitis B. The overall prevalence of hepatitis B for both sites was 9.42%. In the multivariate analysis, male gender, having an occasional sexual partner, and being aged 30–49 years were statistically associated with hepatitis B virus infection.
Conclusion
The prevalence of viral hepatitis B remains high in our region. Providing free screening, treatment, and vaccination against hepatitis B could help reverse this trend.
References
Trépo C, Chan HLY, Lok A. Hepatitis B virus infection. Lancet. 6 déc 2014;384(9959):2053‑63. doi:10.1016/S0140-6736(14)60220-8 PubMed PMID: 24954675.
Global hepatitis report 2024: action for access in low- and middle-income countries [Internet]. [cité 6 mars 2026]. Disponible sur: https://www.who.int/publications/i/item/9789240091672
Global hepatitis report, 2017 [Internet]. [cité 5 mars 2026]. Disponible sur: https://www.who.int/publications/i/item/9789241565455
Journée mondiale contre l’hépatite 2023 | OMS | Bureau régional pour l’Afrique [Internet]. 2026 [cité 6 mars 2026]. Disponible sur: https://www.afro.who.int/regional-director/speeches-messages/world-hepatitis-day-2023
Lingani M, Akita T, Ouoba S, Sanou AM, Sugiyama A, Tarnagda Z, et al. High prevalence of hepatitis B infections in Burkina Faso (1996-2017): a systematic review with meta-analysis of epidemiological studies. BMC Public Health. 25 avr 2018;18(1):551. doi:10.1186/s12889-018-5432-7 PubMed PMID: 29699534; PubMed Central PMCID: PMC5921387.
Ministère de la santé. Annuaire-statistique-2024 , BFA 458 p.
Nagalo BM, Bisseye C, Sanou M, Kienou K, Nebié YK, Kiba A, et al. Seroprevalence and incidence of transfusion-transmitted infectious diseases among blood donors from regional blood transfusion centres in Burkina Faso, West Africa. Trop Med Int Health févr 2012;17(2):247‑53. doi:10.1111/j.1365-3156.2011.02902.x PubMed PMID: 21988100.
Spiegel PB, Checchi F, Colombo S, Paik E. Health-care needs of people affected by conflict: future trends and changing frameworks. Lancet. 23 janv 2010;375(9711):341‑5. doi:10.1016/S0140-6736(09)61873-0 PubMed PMID: 20109961.
Tao I, Compaoré TR, Diarra B, Djigma F, Zohoncon TM, Assih M, et al. Seroepidemiology of hepatitis B and C viruses in the general population of burkina faso. Hepat Res Treat. 2014;2014:781843. doi:10.1155/2014/781843 PubMed PMID: 25161770; PubMed Central PMCID: PMC4138785.
Meda N, Tuaillon E, Kania D, Tiendrebeogo A, Pisoni A, Zida S, et al. Hepatitis B and C virus seroprevalence, Burkina Faso: a cross-sectional study. Bull World Health Organ. 1 nov 2018;96(11):750‑9. doi:10.2471/BLT.18.208603 PubMed PMID: 30455530; PubMed Central PMCID: PMC6239015.
Schweitzer A, Horn J, Mikolajczyk RT, Krause G, Ott JJ. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. Lancet. 17 oct 2015;386(10003):1546‑55. doi:10.1016/S0140-6736(15)61412-X PubMed PMID: 26231459.
Ott JJ, Stevens GA, Groeger J, Wiersma ST. Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity. Vaccine. 9 mars 2012;30(12):2212‑9. doi:10.1016/j.vaccine.2011.12.116 PubMed PMID: 22273662.
Zampino R, Boemio A, Sagnelli C, Alessio L, Adinolfi LE, Sagnelli E, et al. Hepatitis B virus burden in developing countries. World J Gastroenterol. 14 nov 2015;21(42):11941‑53. doi:10.3748/wjg.v21.i42.11941 PubMed PMID: 26576083; PubMed Central PMCID: PMC4641116.
Sticher JS, Csermak KR, Otsyula N, Turkson M, Aubrun E, Oshagbemi OA. Prevalence of viral hepatitis in sub-Saharan Africa among the general population: an umbrella review of systematic reviews and meta-analyses. BMJ Open. 2 sept 2025;15(9):e101029. doi:10.1136/bmjopen-2025-101029 PubMed PMID: 40897496; PubMed Central PMCID: PMC12406870.
Les hépatites virales : situation épidémiologique et transmission | AFRAPEDIA [Internet]. 2023 [cité 16 mars 2026]. Disponible sur: https://www.afrapedia.org/hepatites-virales/les-hepatites-virales-situation-epidemiologique-et-transmission
Stockdale AJ, Mitambo C, Everett D, Geretti AM, Gordon MA. Epidemiology of hepatitis B, C and D in Malawi: systematic review. BMC Infect Dis. 12 oct 2018;18(1):516. doi:10.1186/s12879-018-3428-7 PubMed PMID: 30314448; PubMed Central PMCID: PMC6186098.
Fokam J, Dama A, Yaba B, Malama T, Tjek P, Pamen JNB, et al. Épidémiologie des infections virales (VIH, hépatites B et C) exige des interventions prioritaires pour l´élimination de l´hépatite B: une investigation dans l´Extrême-Nord du Cameroun. The Pan African Medical Journal. 29 janv 2026;53(45). doi:10.11604/pamj.2026.53.45.46297
Olakunde BO, Adeyinka DA, Olakunde OA, Eneh SC, Ogundipe T. Epidemiology of Hepatitis B Virus Infection in Nigeria: A Narrative Review of Prevalence, Transmission, Genotypes, Coinfections, and Mortality. J Trop Med. 2025;2025:4939367. doi:10.1155/jotm/4939367 PubMed PMID: 41050435; PubMed Central PMCID: PMC12494470.
Ayamekpe K, Nadjir KL, Améyissa AA, Kindé RM, Koudéma WL, Gnansa PC, et al. Prévalence et facteurs associés aux hépatites virales B et C chez les primo-donneurs de sang au Centre National de Transfusion Sanguine de Lomé de 2020-2022. Journal of Interventional epidemiology and Public Health. 16 juin 2025;8(2). doi:10.37432/jieph-d-25-00022
Kpossou AR, Paraiso MN, Sokpon CN, Alassan KS, Vignon RK, Keke RK, et al. Hépatite virale B lors d´une campagne de dépistage en population générale au Bénin: séroprévalence et facteurs associés. Pan Afr Med J. 18 nov 2020;37:247. doi:10.11604/pamj.2020.37.247.26070 PubMed PMID: 33552365; PubMed Central PMCID: PMC7847212.
Admin IPD. 28 Juillet 2024, Journée Mondiale de l’hépatite. Institut Pasteur Dakar [Internet]. 28 juill 2024 [cité 6 mars 2026]. Disponible sur: https://institutpasteurdakar.sn/28-juillet-2024-journee-mondiale-de-lhepatite/
Ouedraogo HG, Nikiema AR, Cissé K, Ky-Zerbo O, Samadoulougou BC, Ouedraogo AM, et al. Portage du virus de l’hépatite B chez les travailleuses du sexe dans trois villes secondaires du Burkina Faso: Koudougou, Ouahigouya et Tenkodogo. Revue Malienne d’Infectiologie et de Microbiologie. 4 déc 2019;14(2):32‑42. doi:10.53597/remim.v14i2.1368
Keane E, Funk AL, Shimakawa Y. Systematic review with meta-analysis: the risk of mother-to-child transmission of hepatitis B virus infection in sub-Saharan Africa. Aliment Pharmacol Ther. nov 2016;44(10):1005‑17. doi:10.1111/apt.13795 PubMed PMID: 27630001.
Xiang H, Li M, Xiao M, Liu M, Su X, Wang D, et al. Factors associated with risk behaviours towards hepatitis B among migrant workers: a cross-sectional study based on theory of planned behaviour. BMJ Open. 20 sept 2022;12(9):e056452. doi:10.1136/bmjopen-2021-056452 PubMed PMID: 36127088; PubMed Central PMCID: PMC9490639.
Mukeya Mvumbi G, Dembélé Keïta B, Camara N, Théra I, Guédou FA, Traoré S, et al. Prévalence et facteurs associés aux hépatites B et C chez les travailleuses du sexe de Bamako, Mali. Pan Afr Med J. 2024;49. doi:10.11604/pamj.2024.49.118.39119
Hamidine I, Doffou AS, Kouamé Hatrydt D, Bangoura DA, Yaogo A, Kissi H, et al. Prévalence de l’infection par l’hépatite virale B et facteurs associés chez les enfants des sujets ivoiriens porteurs de l’AGHBS. Mali méd (En ligne) [Internet]. 2023 [cité 16 mars 2026];16‑20. Disponible sur: https://www.malimedical.org/wp-content/uploads/2023/04/4_38_1_2023.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Sciences de la Santé
This work is licensed under a Creative Commons Attribution 4.0 International License.
